Literature DB >> 27927989

Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins.

Satomi Inaba1, Nobutaka Numoto2, Shuhei Ogawa3, Hisayuki Morii4, Teikichi Ikura2, Ryo Abe3, Nobutoshi Ito5, Masayuki Oda6.   

Abstract

Full activation of T cells and differentiation into effector T cells are essential for many immune responses and require co-stimulatory signaling via the CD28 receptor. Extracellular ligand binding to CD28 recruits protein-tyrosine kinases to its cytoplasmic tail, which contains a YMNM motif. Following phosphorylation of the tyrosine, the proteins growth factor receptor-bound protein 2 (Grb2), Grb2-related adaptor downstream of Shc (Gads), and p85 subunit of phosphoinositide 3-kinase may bind to pYMNM (where pY is phosphotyrosine) via their Src homology 2 (SH2) domains, leading to downstream signaling to distinct immune pathways. These three adaptor proteins bind to the same site on CD28 with variable affinity, and all are important for CD28-mediated co-stimulatory function. However, the mechanism of how these proteins recognize and compete for CD28 is unclear. To visualize their interactions with CD28, we have determined the crystal structures of Gads SH2 and two p85 SH2 domains in complex with a CD28-derived phosphopeptide. The high resolution structures obtained revealed that, whereas the CD28 phosphopeptide bound to Gads SH2 is in a bent conformation similar to that when bound to Grb2 SH2, it adopts a more extended conformation when bound to the N- and C-terminal SH2 domains of p85. These differences observed in the peptide-protein interactions correlated well with the affinity and other thermodynamic parameters for each interaction determined by isothermal titration calorimetry. The detailed insight into these interactions reported here may inform the development of compounds that specifically inhibit the association of CD28 with these adaptor proteins to suppress excessive T cell responses, such as in allergies and autoimmune diseases.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Src homology 2 domain (SH2 domain); crystal structure; isothermal titration calorimetry (ITC); protein-protein interaction; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27927989      PMCID: PMC5247639          DOI: 10.1074/jbc.M116.755173

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Alternative modes of binding of proteins with tandem SH2 domains.

Authors:  R O'Brien; P Rugman; D Renzoni; M Layton; R Handa; K Hilyard; M D Waterfield; P C Driscoll; J E Ladbury
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

Authors:  E J Lowenstein; R J Daly; A G Batzer; W Li; B Margolis; R Lammers; A Ullrich; E Y Skolnik; D Bar-Sagi; J Schlessinger
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

3.  Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation.

Authors:  Ryosuke Watanabe; Yohsuke Harada; Kei Takeda; Jun Takahashi; Kazunobu Ohnuki; Shuhei Ogawa; Daisuke Ohgai; Nanako Kaibara; Osamu Koiwai; Kazunari Tanabe; Hiroshi Toma; Kazuo Sugamura; Ryo Abe
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 4.  The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.

Authors:  Bernard A Liu; Brett W Engelmann; Piers D Nash
Journal:  FEBS Lett       Date:  2012-05-05       Impact factor: 4.124

5.  Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus.

Authors:  Lino L Teichmann; Jaime L Cullen; Michael Kashgarian; Chen Dong; Joe Craft; Mark J Shlomchik
Journal:  Immunity       Date:  2015-03-17       Impact factor: 31.745

6.  Reevaluation of stoichiometry and affinity/avidity in interactions between anti-hapten antibodies and mono- or multi-valent antigens.

Authors:  M Oda; T Azuma
Journal:  Mol Immunol       Date:  2000-12       Impact factor: 4.407

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT.

Authors:  H Asada; N Ishii; Y Sasaki; K Endo; H Kasai; N Tanaka; T Takeshita; S Tsuchiya; T Konno; K Sugamura
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

Review 9.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

10.  A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).

Authors:  Yohsuke Harada; Daisuke Ohgai; Ryosuke Watanabe; Kazuhiro Okano; Osamu Koiwai; Kazunari Tanabe; Hiroshi Toma; Amnon Altman; Ryo Abe
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more
  5 in total

1.  Incorporation of Oxidized Phenylalanine Derivatives into Insulin Signaling Relevant Proteins May Link Oxidative Stress to Signaling Conditions Underlying Chronic Insulin Resistance.

Authors:  Judit Mohás-Cseh; Gergő Attila Molnár; Marianna Pap; Boglárka Laczy; Tibor Vas; Melinda Kertész; Krisztina Németh; Csaba Hetényi; Orsolya Csikós; Gábor K Tóth; Attila Reményi; István Wittmann
Journal:  Biomedicines       Date:  2022-04-22

2.  Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK.

Authors:  Natasha S Clayton; Millie Fox; Jose J Vicenté-Garcia; Courtney M Schroeder; Trevor D Littlewood; Jonathon I Wilde; Kadalmani Krishnan; Murray J B Brown; Claire Crafter; Helen R Mott; Darerca Owen
Journal:  J Biol Chem       Date:  2022-04-13       Impact factor: 5.486

Review 3.  Recent Advances in Allogeneic CAR-T Cells.

Authors:  Dong Wook Kim; Je-Yoel Cho
Journal:  Biomolecules       Date:  2020-02-10

Review 4.  SH2 Domain Binding: Diverse FLVRs of Partnership.

Authors:  Rachel Jaber Chehayeb; Titus J Boggon
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

5.  Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases.

Authors:  Xinran Li; Amy Y T Lau; Angel S N Ng; Abdullah Aldehaiman; Yuan Zhou; Patrick K S Ng; Stefan T Arold; Lydia W T Cheung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.